13F-HR filed by Krensavage Asset Management, LLC
Krensavage Asset Management, LLC filed this 13F-HR for the quarter ended 2021-09-30, filed 2021-11-16, with 13 holding rows worth $318,782,000.
- Accession
- 0001609251-21-000006
- Filer
- CIK 1609251
- Filed
- 2021-11-16
- Accepted by EDGAR
- acceptance time not in the bulk data set
- Ingested
- Source
- SEC quarterly data set
13F report for Q3 2021
A holdings report, 13 entries on the cover page, a total value of $318,782,000 stated on the cover page (in dollars after the unit check, H1), rows summing to $318,782,000 with VALUE read as thousands by filing date, 13F file number 028-16807. The quarter's positions are built on this report. The resolved quarter.
The information table after summing rows of one CUSIP and put or call (H4), with the CUSIP and issuer name as filed. Values in dollars after the unit check (method).
| Issuer as filed | CUSIP | Class | Amount | Value | Value read as | Type |
|---|---|---|---|---|---|---|
| ENANTA PHARMACEUTICALS INC | 29251M106 | COM | 936,777 | $53,218,000 | thousands by filing date | |
| ALKERMES PLC | G01767105 | SHS | 1,441,967 | $44,470,000 | thousands by filing date | |
| REGENERON PHARMACEUTICALS COM | 75886F107 | Stock | 73,143 | $44,265,000 | thousands by filing date | |
| UNITED THERAPEUTICS CORP DEL COM | 91307C102 | Stock | 207,287 | $38,261,000 | thousands by filing date | |
| TARO PHARMACEUTICAL INDS LTD | M8737E108 | SHS | 545,583 | $34,715,000 | thousands by filing date | |
| MCKESSON CORP COM | 58155Q103 | Stock | 164,591 | $32,816,000 | thousands by filing date | |
| BIOGEN INC COM | 09062X103 | Stock | 103,202 | $29,205,000 | thousands by filing date | |
| EXELIXIS INC COM | 30161Q104 | Stock | 1,000,000 | $21,140,000 | thousands by filing date | |
| SURGALIGN HOLDINGS INC | 86882C105 | COM | 6,332,945 | $6,903,000 | thousands by filing date | |
| EAGLE PHARMACEUTICALS INC | 269796108 | COM | 107,773 | $6,012,000 | thousands by filing date | |
| INVACARE CORP | 461203101 | COMMON STOCK | 891,259 | $4,242,000 | thousands by filing date | |
| TRAVERE THERAPEUTICS INC | 89422G107 | COM | 137,203 | $3,327,000 | thousands by filing date | |
| NEXTCURE INC | 65343E108 | COM | 30,927 | $208,000 | thousands by filing date |
Amendment chain
| Filing | Role | Filed | Accepted | Ingested |
|---|---|---|---|---|
| 13F-HR 0001609251-21-000006 | this filing | 2021-11-16 | acceptance time not in the bulk data set |